[1]
McKenzie MS, McFarland BH. Trends in antidepressant overdoses. Pharmacoepidemiology and drug safety. 2007 May:16(5):513-23
[PubMed PMID: 17200994]
[2]
Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Current pharmaceutical design. 2004:10(20):2463-75
[PubMed PMID: 15320756]
[3]
Hasnain M, Howland RH, Vieweg WV. Escitalopram and QTc prolongation. Journal of psychiatry & neuroscience : JPN. 2013 Jul:38(4):E11. doi: 10.1503/jpn.130055. Epub
[PubMed PMID: 23791140]
[4]
Vieweg WV,Hasnain M,Howland RH,Hettema JM,Kogut C,Wood MA,Pandurangi AK, Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling? The American journal of medicine. 2012 Sep
[PubMed PMID: 22748401]
[5]
Pacher P, Ungvari Z, Kecskemeti V, Furst S. Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants. Current medicinal chemistry. 1998 Oct:5(5):381-90
[PubMed PMID: 9756980]
[6]
Varela Piñón M, Adán-Manes J. Selective Serotonin Reuptake Inhibitor-Induced Hyponatremia: Clinical Implications and Therapeutic Alternatives. Clinical neuropharmacology. 2017 Jul/Aug:40(4):177-179. doi: 10.1097/WNF.0000000000000221. Epub
[PubMed PMID: 28622213]
[7]
Marken PA, Munro JS. Selecting a Selective Serotonin Reuptake Inhibitor: Clinically Important Distinguishing Features. Primary care companion to the Journal of clinical psychiatry. 2000 Dec:2(6):205-210
[PubMed PMID: 15014630]
[8]
Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. Journal of toxicology. Clinical toxicology. 2004:42(3):277-85
[PubMed PMID: 15362595]
[9]
Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues in clinical neuroscience. 2007:9(1):47-59
[PubMed PMID: 17506225]
[10]
Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM : monthly journal of the Association of Physicians. 2003 Sep:96(9):635-42
[PubMed PMID: 12925718]
[11]
Gillman PK. Serotonin syndrome: history and risk. Fundamental & clinical pharmacology. 1998:12(5):482-91
[PubMed PMID: 9794145]
[13]
Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment. The Medical journal of Australia. 2007 Sep 17:187(6):361-5
[PubMed PMID: 17874986]
[14]
Frank C. Recognition and treatment of serotonin syndrome. Canadian family physician Medecin de famille canadien. 2008 Jul:54(7):988-92
[PubMed PMID: 18625822]
[15]
Foong AL,Grindrod KA,Patel T,Kellar J, Demystifying serotonin syndrome (or {i}serotonin toxicity{/i}). Canadian family physician Medecin de famille canadien. 2018 Oct
[PubMed PMID: 30315014]
[16]
Bartlett D. Drug-Induced Serotonin Syndrome. Critical care nurse. 2017 Feb:37(1):49-54. doi: 10.4037/ccn2017169. Epub
[PubMed PMID: 28148614]
[17]
Sundaramurthy S, Annamalai B, Samuvel DJ, Shippenberg TS, Jayanthi LD, Ramamoorthy S. Modulation of serotonin transporter function by kappa-opioid receptor ligands. Neuropharmacology. 2017 Feb:113(Pt A):281-292. doi: 10.1016/j.neuropharm.2016.10.011. Epub 2016 Oct 12
[PubMed PMID: 27743931]
[18]
Barann M, Stamer UM, Lyutenska M, Stüber F, Bönisch H, Urban B. Effects of opioids on human serotonin transporters. Naunyn-Schmiedeberg's archives of pharmacology. 2015 Jan:388(1):43-9. doi: 10.1007/s00210-014-1056-3. Epub 2014 Oct 22
[PubMed PMID: 25332055]
[19]
Rickli A, Liakoni E, Hoener MC, Liechti ME. Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome. British journal of pharmacology. 2018 Feb:175(3):532-543. doi: 10.1111/bph.14105. Epub 2018 Jan 6
[PubMed PMID: 29210063]
[20]
Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British journal of anaesthesia. 2005 Oct:95(4):434-41
[PubMed PMID: 16051647]
[21]
Baldo BA. Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects. Archives of toxicology. 2018 Aug:92(8):2457-2473. doi: 10.1007/s00204-018-2244-6. Epub 2018 Jun 18
[PubMed PMID: 29916050]
Level 3 (low-level) evidence
[22]
Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Clinical toxicology (Philadelphia, Pa.). 2017 Dec:55(10):1072-1252. doi: 10.1080/15563650.2017.1388087. Epub 2017 Nov 29
[PubMed PMID: 29185815]
[23]
Barbey JT, Roose SP. SSRI safety in overdose. The Journal of clinical psychiatry. 1998:59 Suppl 15():42-8
[PubMed PMID: 9786310]
[24]
Nelson LS, Erdman AR, Booze LL, Cobaugh DJ, Chyka PA, Woolf AD, Scharman EJ, Wax PM, Manoguerra AS, Christianson G, Caravati EM, Troutman WG. Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management. Clinical toxicology (Philadelphia, Pa.). 2007 May:45(4):315-32
[PubMed PMID: 17486478]
Level 3 (low-level) evidence
[25]
Nisijima K, Shioda K, Yoshino T, Takano K, Kato S. Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. Neurochemistry international. 2003 Jul:43(2):155-64
[PubMed PMID: 12620284]
Level 3 (low-level) evidence
[26]
Tanii H, Taniguchi N, Niigawa H, Hosono T, Ikura Y, Sakamoto S, Kudo T, Nishimura T, Takeda M. Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level. Brain research. 1996 Dec 16:743(1-2):263-70
[PubMed PMID: 9017254]
Level 3 (low-level) evidence
[27]
Eyer F, Zilker T. Bench-to-bedside review: mechanisms and management of hyperthermia due to toxicity. Critical care (London, England). 2007:11(6):236
[PubMed PMID: 18096088]
[28]
Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. The Journal of emergency medicine. 1998 Jul-Aug:16(4):615-9
[PubMed PMID: 9696181]
[29]
Birmes P, Coppin D, Schmitt L, Lauque D. Serotonin syndrome: a brief review. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2003 May 27:168(11):1439-42
[PubMed PMID: 12771076]
[30]
Stoner SC,Marken PA,Watson WA,Switzer JL,Barber MF,Meyer VL,Sommi RW Jr,Steele MT, Antidepressant overdoses and resultant emergency department services: the impact of SSRIs. Psychopharmacology bulletin. 1997
[PubMed PMID: 9493477]